Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
Background: Peripheral artery disease (PAD) patients undergoing infrainguinal angioplasty with stenting suffer high rates of target lesion restenosis and ischemic events. Blood-based prognostic markers in these patients are currently limited. The IL-33/ST2-system is involved in atherothrombosis. Sol...
Main Authors: | Stefan Stojkovic, Svitlana Demyanets, Christoph W. Kopp, Christian Hengstenberg, Johann Wojta, Beate Eichelberger, Simon Panzer, Thomas Gremmel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.605669/full |
Similar Items
-
Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease—A 10-Year Cohort Study
by: Matthias H. Urban, et al.
Published: (2021-12-01) -
Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome
by: Stefan Stojkovic, et al.
Published: (2023-05-01) -
The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
by: Svitlana Demyanets, et al.
Published: (2020-02-01) -
Soluble ST2 as a Potential Biomarker for Abdominal Aortic Aneurysms—A Single-Center Retrospective Cohort Study
by: Johannes Klopf, et al.
Published: (2022-08-01) -
The Paradigm Change of IL-33 in Vascular Biology
by: Svitlana Demyanets, et al.
Published: (2021-12-01)